234 related articles for article (PubMed ID: 36352530)
1. Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.
Tang Z; Sun C; Yan Y; Niu Z; Li Y; Xu X; Zhang J; Wu Y; Li Y; Wang L; Hu C; Li Z; Jiang J; Ying H
J Mol Cell Biol; 2023 Feb; 14(9):. PubMed ID: 36352530
[TBL] [Abstract][Full Text] [Related]
2. GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m
Hu Y; Feng Y; Zhang L; Jia Y; Cai D; Qian SB; Du M; Zhao R
RNA Biol; 2020 Jul; 17(7):930-942. PubMed ID: 32116145
[TBL] [Abstract][Full Text] [Related]
3. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
4. F6P/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish.
Gong Y; Lu Q; Xi L; Liu Y; Yang B; Su J; Liu H; Jin J; Zhang Z; Yang Y; Zhu X; Xie S; Han D
J Nutr Biochem; 2023 Dec; 122():109452. PubMed ID: 37748621
[TBL] [Abstract][Full Text] [Related]
5. FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells.
Chen A; Chen X; Cheng S; Shu L; Yan M; Yao L; Wang B; Huang S; Zhou L; Yang Z; Liu G
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):538-548. PubMed ID: 29486327
[TBL] [Abstract][Full Text] [Related]
6. Fat mass and obesity-associated protein promotes liver steatosis by targeting PPARα.
Wei X; Zhang J; Tang M; Wang X; Fan N; Peng Y
Lipids Health Dis; 2022 Mar; 21(1):29. PubMed ID: 35282837
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
8. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
[TBL] [Abstract][Full Text] [Related]
9. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
10. METTL16-mediated translation of
Tang J; Zhao X; Wei W; Liu W; Fan H; Liu XP; Li Y; Wang L; Guo J
PeerJ; 2022; 10():e14379. PubMed ID: 36518278
[TBL] [Abstract][Full Text] [Related]
11. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
[TBL] [Abstract][Full Text] [Related]
12. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
[TBL] [Abstract][Full Text] [Related]
13. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
14. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
Cha JY; Repa JJ
J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
[TBL] [Abstract][Full Text] [Related]
15. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
[TBL] [Abstract][Full Text] [Related]
16. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
17. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
[TBL] [Abstract][Full Text] [Related]
18. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
19. FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice.
Chen J; Zhou X; Wu W; Wang X; Wang Y
J Physiol Biochem; 2015 Sep; 71(3):405-13. PubMed ID: 26078098
[TBL] [Abstract][Full Text] [Related]
20. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
